CoChat
Sign Up
Cited by 60

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands

Cahill, Michael A., Medlock, Amy E.·2017·The Journal of Steroid Biochemistry and Molecular Biology
DOI 10.1016/j.jsbmb.2016.12.020
Open this paper in CoChat — free account

Abstract

Progesterone Receptor Membrane Component 1 (PGRMC1) is located in many different subcellular locations with many different attested and probably location-specific functions. PGRMC1 was recently identified in the mitochondrial outer membrane where it interacts with ferrochelatase, the last enzyme in the heme synthetic pathway. It has been proposed that PGRMC1 may act as a chaperone to shuttle newly synthesized heme from the mitochondrion to cytochrome P450 (cyP450) enzymes. Here we consider potential roles that PGRMC1 may play in transferring heme, and other small hydrophobic ligands such as cholesterol and steroids, between the hydrophobic compartment of the membrane lipid bilayer interior to aqueous proteins, and perhaps to the membranes of other organelles. We review the synthesis and roles of especially PGRMC1- and cyP450-bound heme, the sources and transport of cholesterol, the involvement of PGRMC1 in cholesterol regulation, and the production of the first progestogen pregnenolone from cholesterol. We also show by clustering by inferred models of evolution (CLIME) analysis that PGRMC1 and related proteins exhibit co-evolution with a series of cyP450 enzymes, as well as a group of mitochondrial proteins lacking in several parasitic protist groups. Altogether, PGRMC1 is implicated with important roles in sterol synthesis and energy regulation that are dispensable in certain parasites. Some novel hypothetical models for PGRMC1 function are proposed to direct future investig…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jsbmb.2016.12.020

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 106

  1. Cahill, 2007, Progesterone receptor membrane component 1: an integrative review, J. Steroid Biochem. Mol. Biol., 105, 16, 10.1016/j.jsbmb.2007.02.002 · DOI
  2. Cahill, 2016, The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology, Biochim. Biophys. Acta
  3. Ahmed, 2012, S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling, Exp. Opin. Drug Metab. Toxicol., 8, 361, 10.1517/17425255.2012.658367 · DOI · Paper page
  4. Thomas, 2008, Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions, Front. Neuroendocrinol., 29, 292, 10.1016/j.yfrne.2008.01.001 · DOI
  5. Peluso, 2013, Progesterone receptor membrane component 1 and its role in ovarian follicle growth, Front. Neurosci., 7, 99, 10.3389/fnins.2013.00099 · DOI
  6. Peluso, 2014, Non-canonical progesterone signaling in granulosa cell function, Reprod. (Camb. Engl.), 147, R169, 10.1530/REP-13-0582 · DOI
  7. Mifsud, 2002, Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain, Genome Biol., 3, 10.1186/gb-2002-3-12-research0068 · DOI
  8. Kimura, 2012, Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins, Curr. Protein Pept. Sci., 13, 687, 10.2174/138920312804142110 · DOI
  9. Petersen, 2013, Nonclassical progesterone signalling molecules in the nervous system, J. Neuroendocrinol., 25, 991, 10.1111/jne.12060 · DOI
  10. Mayer, 1998, Functions of SH2 and SH3 domains, Curr. Top. Microbiol. Immunol., 228, 1
  11. Cahill, 2016, PGRMC1 regulation by phosphorylation: potential new insights in controlling biological activity!, Oncotarget, 10.18632/oncotarget.10691 · DOI
  12. Piel, 2016, A novel role for progesterone receptor membrane component 1 (PGRMC1): a partner and regulator of ferrochelatase, Biochemistry, 55, 5204, 10.1021/acs.biochem.6b00756 · DOI
  13. Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol. Chem., 379, 907
  14. Min, 2005, Molecular identification of adrenal inner zone antigen as a heme-binding protein, FEBS J., 272, 5832, 10.1111/j.1742-4658.2005.04977.x · DOI
  15. Min, 2004, Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis, Mol. Cell. Endocrinol., 215, 143, 10.1016/j.mce.2003.11.025 · DOI
  16. Oda, 2011, Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner, Drug Metab. Dispos.: Biol Fate Chem., 39, 2057, 10.1124/dmd.111.040907 · DOI
  17. Ghosh, 2005, Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1p, Biochemistry, 44, 16729, 10.1021/bi0511585 · DOI
  18. Thompson, 2007, Measurement of the heme affinity for yeast dap1p, and its importance in cellular function, Biochemistry, 46, 14629, 10.1021/bi7013739 · DOI
  19. Kaluka, 2015, Spectroscopic and mutagenesis studies of human PGRMC1, Biochemistry, 54, 1638, 10.1021/bi501177e · DOI
  20. Kabe, 2016, Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance, Nat. Commun., 7, 11030, 10.1038/ncomms11030 · DOI · Paper page
  21. Mills, 2005, An arginine to lysine mutation in the vicinity of the heme propionates affects the redox potentials of the hemes and associated electron and proton transfer in cytochrome c oxidase, Biochemistry, 44, 10457, 10.1021/bi050283d · DOI
  22. Caillet-Saguy, 2012, Role of the iron axial ligands of heme carrier HasA in heme uptake and release, J. Biol. Chem., 287, 26932, 10.1074/jbc.M112.366385 · DOI
  23. Eakanunkul, 2005, Characterization of the periplasmic heme-binding protein shut from the heme uptake system of Shigella dysenteriae, Biochemistry, 44, 13179, 10.1021/bi050422r · DOI
  24. Tong, 2007, Cloning and characterization of a novel periplasmic heme-transport protein from the human pathogen Pseudomonas aeruginosa, Journal of biological inorganic chemistry, JBIC: Publ. Soc. Biol. Inorg. Chem., 12, 735, 10.1007/s00775-007-0226-x · DOI
  25. Wegiel, 2013, Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth, Cancer Res., 73, 7009, 10.1158/0008-5472.CAN-13-1075 · DOI
  26. Kabe, 2016, Cystathionine beta-synthase and PGRMC1 as CO sensors, Free Radic. Biol. Med., 99, 333, 10.1016/j.freeradbiomed.2016.08.025 · DOI · Paper page
  27. Suematsu, 2016, CO-CBS-H2 S axis from vascular mediator to cancer regulator, Microcirc. (New York N.Y.: 1994), 23, 183, 10.1111/micc.12253 · DOI
  28. Morikawa, 2012, Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway, Proc. Natl. Acad. Sci. U. S. A., 109, 1293, 10.1073/pnas.1119658109 · DOI
  29. Neubauer, 2008, Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1, Breast Cancer Res., 10, R85, 10.1186/bcr2155 · DOI
  30. Raza, 2001, Identification of the rat adrenal zona fasciculata/reticularis specific protein inner zone antigen (IZAg), as the putative membrane progesterone receptor, Eur. J. Biochem./FEBS, 268, 2141, 10.1046/j.1432-1327.2001.02096.x · DOI
  31. Medlock, 2015, Identification of the mitochondrial heme metabolism complex, PLoS One, 10, e0135896, 10.1371/journal.pone.0135896 · DOI
  32. Chiabrando, 2012, The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation, J. Clin. Invest., 122, 4569, 10.1172/JCI62422 · DOI
  33. Reddi, 2016, Heme mobilization in animals: a metallolipid’s journey, Acc. Chem. Res., 49, 1104, 10.1021/acs.accounts.5b00553 · DOI
  34. Chakravarti, 2010, GAPDH regulates cellular heme insertion into inducible nitric oxide synthase, Proc. Natl. Acad. Sci. U. S. A., 107, 18004, 10.1073/pnas.1008133107 · DOI
  35. Schenkman, 2003, The many roles of cytochrome b5, Pharmacol. Ther., 97, 139, 10.1016/S0163-7258(02)00327-3 · DOI
  36. Hughes, 2007, Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes, Cell Metab., 5, 143, 10.1016/j.cmet.2006.12.009 · DOI · Paper page
  37. Szczesna-Skorupa, 2011, Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase, Mol. Pharmacol., 79, 340, 10.1124/mol.110.068478 · DOI
  38. Rohe, 2009, PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding, Pharmacol. Ther., 121, 14, 10.1016/j.pharmthera.2008.09.006 · DOI · Paper page
  39. Li, 2014, Expansion of biological pathways based on evolutionary inference, Cell, 158, 213, 10.1016/j.cell.2014.05.034 · DOI · Paper page
  40. Wang, 2013, WEB-based GEne SeT analysis toolkit (WebGestalt): update 2013, Nucleic Acids Res., 41, W77, 10.1093/nar/gkt439 · DOI
  41. Michel, 2012, The ERMES complex and ER-mitochondria connections, Biochem. Soc. Trans., 40, 445, 10.1042/BST20110758 · DOI
  42. Baker, 2003, Evolution of adrenal and sex steroid action in vertebrates: a ligand-based mechanism for complexity, BioEssays: news and reviews in molecular, Cell. Dev. Biol., 25, 396
  43. Baker, 2011, Origin and diversification of steroids: co-evolution of enzymes and nuclear receptors, Mol. Cell. Endocrinol., 334, 14, 10.1016/j.mce.2010.07.013 · DOI
  44. Goldstone, 2016, Genetic and structural analyses of cytochrome P450 hydroxylases in sex hormone biosynthesis: sequential origin and subsequent coevolution, Mol. Phylogenet. Evol., 94, 676, 10.1016/j.ympev.2015.09.012 · DOI
  45. Berriman, 2009, The genome of the blood fluke Schistosoma mansoni, Nature, 460, 352, 10.1038/nature08160 · DOI
  46. Spector, 2015, Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism, Biochim. Biophys. Acta, 1851, 356, 10.1016/j.bbalip.2014.07.020 · DOI
  47. Whitfield, 1999, Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function, J. Cell. Biochem., 110, 10.1002/(SICI)1097-4644(1999)75:32+<110::AID-JCB14>3.0.CO;2-T · DOI
  48. Price, 2013, Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved?, Menopause, 20, 486, 10.1097/GME.0b013e318287f30e · DOI
  49. Ji, 2012, Expression of progesterone receptor membrane component-1 is associated with the malignant phenotypes of breast cancer, Nan fang yi ke da xue xue bao, 32, 635
  50. Hu, 2010, Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones, Nutr. Metab., 7, 47, 10.1186/1743-7075-7-47 · DOI
  51. Du, 2013, Endosomal cholesterol trafficking: protein factors at a glance, Acta Biochim. Biophys. Sin., 45, 11, 10.1093/abbs/gms095 · DOI
  52. Zhang, 2015, Cholesterol metabolism and homeostasis in the brain, Protein Cell, 6, 254, 10.1007/s13238-014-0131-3 · DOI · Paper page
  53. Ribas, 2016, Mitochondria, cholesterol and cancer cell metabolism, Clin. Trans. Med., 5, 22, 10.1186/s40169-016-0106-5 · DOI
  54. Kuzu, 2016, The role of cholesterol in cancer, Cancer Res., 76, 2063, 10.1158/0008-5472.CAN-15-2613 · DOI
  55. Fessler, 2016, The intracellular cholesterol landscape: dynamic integrator of the immune response, Trends Immunol., 10.1016/j.it.2016.09.001 · DOI
  56. Morgan, 2016, Cholesterol metabolism: a review of how ageing disrupts the biological mechanisms responsible for its regulation, Ageing Res. Rev., 27, 108, 10.1016/j.arr.2016.03.008 · DOI
  57. Olson, 1998, Discovery of the lipoproteins, their role in fat transport and their significance as risk factors, J. Nutr., 128, 439s, 10.1093/jn/128.2.439S · DOI
  58. Miller, 2013, Steroid hormone synthesis in mitochondria, Mol. Cell. Endocrinol., 379, 62, 10.1016/j.mce.2013.04.014 · DOI
  59. Wustner, 2015, How cholesterol interacts with proteins and lipids during its intracellular transport, Biochim. Biophys. Acta, 1848, 1908, 10.1016/j.bbamem.2015.05.010 · DOI
  60. Choudhury, 2002, Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells, J. Clin. Invest., 109, 1541, 10.1172/JCI0215420 · DOI
  61. Walter, 2003, Telomerase immortalization upregulates Rab9 expression and restores LDL cholesterol egress from Niemann-Pick C1 late endosomes, J. Lipid Res., 44, 243, 10.1194/jlr.M200230-JLR200 · DOI
  62. Miller, 2011, Early steps in steroidogenesis: intracellular cholesterol trafficking, J. Lipid Res., 52, 2111, 10.1194/jlr.R016675 · DOI
  63. Brown, 1997, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, 89, 331, 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
  64. Brown, 1996, Nobel laureates in medicine, J. Investig. Med., 44, 14
  65. Buhaescu, 2007, Mevalonate pathway: a review of clinical and therapeutical implications, Clin. Biochem., 40, 575, 10.1016/j.clinbiochem.2007.03.016 · DOI · Paper page
  66. Laird, 1988, Monoclonal antibodies against rat adrenocortical cell antigens, Acta Endocrinol., 119, 420
  67. Suchanek, 2005, Photo-leucine and photo-methionine allow identification of protein–protein interactions in living cells, Nat. Methods, 2, 261, 10.1038/nmeth752 · DOI
  68. Shao, 2012, Expanding roles for SREBP in metabolism, Cell Metab., 16, 414, 10.1016/j.cmet.2012.09.002 · DOI
  69. Cheng, 2015, Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth, Cancer Cell, 28, 569, 10.1016/j.ccell.2015.09.021 · DOI
  70. Shao, 2015, Sugar makes fat by talking to SCAP, Cancer Cell, 28, 548, 10.1016/j.ccell.2015.10.011 · DOI
  71. Neubauer, 2009, Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells, Climacteric, 12, 230, 10.1080/13697130802635637 · DOI
  72. Beebe, 2006, The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats, Behav. Brain Res., 171, 225, 10.1016/j.bbr.2006.03.039 · DOI
  73. Gross, 2010, Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men, Obesity (Silver Spring Md.), 18, 2295, 10.1038/oby.2010.51 · DOI
  74. Gross, 2009, Mifepristone treatment of olanzapine-induced weight gain in healthy men, Adv. Ther., 26, 959, 10.1007/s12325-009-0070-1 · DOI
  75. Lange, 1998, Circulation of cholesterol between lysosomes and the plasma membrane, J. Biol. Chem., 273, 18915, 10.1074/jbc.273.30.18915 · DOI
  76. Urbe, 2005, Ubiquitin and endocytic protein sorting, Essays Biochem., 41, 81, 10.1042/bse0410081 · DOI
  77. Moreno-Gonzalo, 2014, Post-translational modifications of exosomal proteins, Front. Immunol., 5, 383, 10.3389/fimmu.2014.00383 · DOI
  78. Mir, 2012, Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients, Int. J. Cancer, 131, E1, 10.1002/ijc.26432 · DOI
  79. Mobius, 2003, Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway, Traffic (Copenhagen Denmark), 4, 222, 10.1034/j.1600-0854.2003.00072.x · DOI
  80. Selvaraj, 2016, Current status and future perspectives: TSPO in steroid neuroendocrinology, J. Endocrinol., 231, R1, 10.1530/JOE-16-0241 · DOI
  81. Issop, 2013, Organelle plasticity and interactions in cholesterol transport and steroid biosynthesis, Mol. Cell. Endocrinol., 371, 34, 10.1016/j.mce.2012.12.003 · DOI
  82. Churchill, 1979, Topological studies of cytochromes P-450scc and P-45011 beta in bovine adrenocortical inner mitochondrial membranes. Effects of controlled tryptic digestion, J. Biol. Chem., 254, 10443, 10.1016/S0021-9258(19)86728-5 · DOI
  83. Guennoun, 2015, Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection, J. Steroid Biochem. Mol. Biol., 146, 48, 10.1016/j.jsbmb.2014.09.001 · DOI
  84. McCallum, 2016, Conditional ablation of progesterone receptor membrane component 1 results in subfertility in the female and development of endometrial cysts, Endocrinology, 157, 3309, 10.1210/en.2016-1081 · DOI
  85. Peluso, 2008, Endocrinology, 149, 534, 10.1210/en.2007-1050 · DOI
  86. Sueldo, 2015, Progestin and AdipoQ receptor 7 progesterone membrane receptor component 1 (PGRMC1), and PGRMC2 and their role in regulating progesterone's ability to suppress human granulosa/luteal cells from entering into the cell cycle, Biol. Reprod., 93, 63, 10.1095/biolreprod.115.131508 · DOI
  87. Peluso, 2014, Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells, Biol. Reprod., 91, 104, 10.1095/biolreprod.114.122986 · DOI
  88. Peluso, 2006, Multiplicity of progesterone’s actions and receptors in the mammalian ovary, Biol. Reprod., 75, 2, 10.1095/biolreprod.105.049924 · DOI
  89. Rekawiecki, 2008, Regulation of progesterone synthesis and action in bovine corpus luteum, J. Physiol. Pharmacol., 59, 75
  90. Baggetto, 1992, Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells, Cancer Res., 52, 4935
  91. Rhayem, 2015, Functional characterization of PRKAR1A mutations reveals a unique molecular mechanism causing acrodysostosis but multiple mechanisms causing carney complex, J. Biol. Chem., 290, 27816, 10.1074/jbc.M115.656553 · DOI
  92. Taylor, 2014, Targeting mitochondrial 18kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype, Clin. Sci. (Lond., Engl.: 1979), 127, 603, 10.1042/CS20140047 · DOI
  93. Freedman, 1951, A note on the solubility of pregnenolone and pregnenolone acetate in various solvents, J. Am. Pharm. Assoc, 40, 54, 10.1002/jps.3030400117 · DOI
  94. Jaremko, 2015, Structure of the mammalian TSPO/PBR protein, Biochem. Soc. Trans., 43, 566, 10.1042/BST20150029 · DOI
  95. Jaremko, 2015, Conformational flexibility in the transmembrane protein TSPO, Chemistry (Weinheim an der Bergstrasse Germany), 21, 16555
  96. Uversky, 2010, Understanding protein non-folding, Biochim. Biophys. Acta, 1804, 1231, 10.1016/j.bbapap.2010.01.017 · DOI
  97. Tsou, 1998, Active site flexibility in enzyme catalysis, Ann. N. Y. Acad. Sci., 864, 1, 10.1111/j.1749-6632.1998.tb10282.x · DOI
  98. Chouard, 2011, Structural biology: breaking the protein rules, Nature, 471, 151, 10.1038/471151a · DOI
  99. Shen, 2014, Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function, Cell Rep., 7, 180, 10.1016/j.celrep.2014.02.042 · DOI
  100. Yoshitani, 2005, A structure-based strategy for discovery of small ligands binding to functionally unknown proteins: combination of in silico screening and surface plasmon resonance measurements, Proteomics, 5, 1472, 10.1002/pmic.200401032 · DOI
  101. Izzo, 2014, Alzheimer’s therapeutics targeting amyloid beta 1–42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity, PLoS One, 9, e111899, 10.1371/journal.pone.0111899 · DOI · Paper page
  102. Creegan, 2015, Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer’s disease pathology?, Br. J. Nutr., 113, 1499, 10.1017/S0007114515000926 · DOI
  103. Hornbeck, 2015, PhosphoSitePlus, 2014 mutations, PTMs and recalibrations, Nucleic Acids Res., 43, D512, 10.1093/nar/gku1267 · DOI · Paper page
  104. Häggström, 2014, Diagram of the pathways of human steroidogenesis, Wikiversity J. Med., 1, 10.15347/wjm/2014.005 · DOI
  105. Griffiths, 2016, Current trends in oxysterol research, Biochem. Soc. Trans., 44, 652, 10.1042/BST20150255 · DOI
  106. Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. Ser. B (Methodol.), 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Cahill, M. A., & Medlock, A. E.
Venue
The Journal of Steroid Biochemistry and Molecular Biology
Publisher
Elsevier BV
Published
2017-07
Volume
171
Pages
11-33
ISSN
0960-0760
DOI
10.1016/j.jsbmb.2016.12.020
Cited by
60
References
13
Language
en
Licence
Funders
  • Australian competitive funding
  • Charles Sturt University (CSU) School of Biomedical Sciences (A534-900-xxx-41066, A102-900-xxx-40002, A541-900-xxx-40513)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review